Intensity-modulated radiation therapy in early stage squamous cell carcinoma of the larynx: treatment trends and outcomes |
Wegner, Rodney E.
(Division of Radiation Oncology, Allegheny Health Network Cancer Institute)
Abel, Stephen (Division of Radiation Oncology, Allegheny Health Network Cancer Institute) Bergin, John J. (Division of Radiation Oncology, Allegheny Health Network Cancer Institute) Colonias, Athanasios (Division of Radiation Oncology, Allegheny Health Network Cancer Institute) |
1 | Zumsteg ZS, Riaz N, Jaffery S, et al. Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma. Oral Oncol 2015;51:716-23. DOI |
2 | Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9. DOI |
3 | Cox DR. Regression models and life-tables. J R Stat Soc Series B Stat Methodol 1972;34:187-220. |
4 | D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81. DOI |
5 | Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81. DOI |
6 | Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:461-6. DOI |
7 | Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87. DOI |
8 | Plummer C, Henderson RD, O'Sullivan JD, Read SJ. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: a review. Stroke 2011;42:2410-8. DOI |
9 | Al-Mamgani A, Kwa SL, Tans L, et al. Single vocal cord irradiation: image guided intensity modulated hypofractionated radiation therapy for T1a Glottic cancer: early clinical results. Int J Radiat Oncol Biol Phys 2015;93:337-43. DOI |
10 | Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993;14:116-21. DOI |
11 | Ambrosch P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 2007;15:82-8. DOI |
12 | Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-T2 glottic carcinomas. Cancer 2004;100:1786-92. DOI |
13 | Bhide SA, Newbold KL, Harrington KJ, Nutting CM. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol 2012;85:487-94. DOI |
14 | American Society of Clinical Oncology, Pfister DG, Laurie SA, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24:3693-704. DOI |
15 | National Comprehensive Cancer Network. NCCN Guidelines: head and neck cancer (Version 2.2019) [Internet]. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2019 [cited 2020 Feb 5]. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx. |
16 | Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 2006;64:77-82. DOI |
17 | Chera BS, Amdur RJ, Morris CG, Mendenhall WM. Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys 2010;77:1380-5. DOI |
18 | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30. DOI |